Ann & Robert H Lurie Children's Hospital of Chicago

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
34	Exempt: No Licensed Adult ICU Beds
48	No Target Procedures Performed
49	Complete Reporting: 20 or Fewer Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
34	Exempt: No Licensed Adult ICU Beds
48	No Target Procedures Performed
49	Complete Reporting: 20 or Fewer Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴
Q1 2009 - Q4 2009 Result N/A infections, N/A central-line days ³⁴ Rating SIR: N/A ³⁴	N/A infections, N/A central-line days ³⁴	N/A ³⁴

Pediatric CLABSI

NICU CLABSI

NICU CLABSI Measure	Result	SIR
Level III Neonatal ICU Q1 2019 - Q4 2019 Result 6 infections, 6642 central-line days Rating SIR: 0.70	6 infections, 6642 central-line days	0.70
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 5 infections, 6028 central-line days Rating SIR: 0.61	5 infections, 6028 central-line days	0.61
Q1 2017 - Q4 2017 Result 3 infections, 5850 central-line days Rating SIR: 0.42	3 infections, 5850 central-line days	0.42
Q1 2016 - Q4 2016 Result 4 infections, 6727 central-line days Rating SIR: 0.47	4 infections, 6727 central-line days	0.47
Q1 2015 - Q4 2015 Result 3 infections, 5533 central-line days Rating SIR: 0.26	3 infections, 5533 central-line days	0.26
Q1 2014 - Q4 2014 Result 3 infections, 4745 central-line days Rating SIR: 0.30	3 infections, 4745 central-line days	0.30
Q1 2013 - Q4 2013 Result 4 infections, 5235 central-line days Rating SIR: 0.34	4 infections, 5235 central-line days	0.34
Q1 2012 - Q4 2012 Result 1 infections, 5794 central-line days Rating SIR: 0.11	1 infections, 5794 central-line days	0.11
Q1 2011 - Q4 2011 Result 9 infections, 5917 central-line days Rating SIR: 0.69	9 infections, 5917 central-line days	0.69
Q1 2010 - Q4 2010 Result 6 infections, 6213 central-line days Rating SIR: 0.44	6 infections, 6213 central-line days	0.44
Q1 2010 - Q2 2010 Result 2 infections, 2811 central-line days Rating SIR: 0.28	2 infections, 2811 central-line days	0.28

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
34	Exempt: No Licensed Adult ICU Beds
48	No Target Procedures Performed
49	Complete Reporting: 20 or Fewer Procedures Performed
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
169	Exempt: No Licensed ICU Beds

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2018 - Q4 2018 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2017 - Q4 2017 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2010 - Q2 2011 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2018 - Q4 2018 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2012 - Q2 2013 Result 0 infections, 1 procedures ⁴⁹ Rating SIR: N/A ⁴⁹	0 infections, 1 procedures ⁴⁹	N/A ⁴⁹
Q3 2010 - Q2 2011 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2017 - Q1 2018 Result N/A %	N/A %
Description Influenza Vaccination Coverage among Healthcare Personnel

Measure

Healthcare workers given influenza vaccination

Q4 2017 - Q1 2018

Result: N/A %

Illinois Hospital Report Card

and Consumer Guide to Health Care

Ann & Robert H Lurie Children's Hospital of Chicago

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Description

Historical Data

Description

Historical Data

Description

Historical Data

NICU CLABSI

Description

Historical Data

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 4 infections, 99891 patient days Rating SIR: 1.02	4 infections, 99891 patient days	1.02
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 6 infections, 94824 patient days Rating SIR: 1.59	6 infections, 94824 patient days	1.59
Q1 2021 - Q4 2021 Result 3 infections, 92736 patient days Rating SIR: 0.71	3 infections, 92736 patient days	0.71
Q1 2020 - Q4 2020 Result 3 infections, 83086 patient days Rating SIR: 0.78	3 infections, 83086 patient days	0.78
Q1 2019 - Q4 2019 Result 7 infections, 92338 patient days Rating SIR: 2.03	7 infections, 92338 patient days	2.03
Q1 2018 - Q4 2018 Result 5 infections, 85610 patient days Rating SIR: 1.69	5 infections, 85610 patient days	1.69
Q1 2017 - Q4 2017 Result 7 infections, 81363 patient days Rating SIR: 1.94	7 infections, 81363 patient days	1.94
Q1 2016 - Q4 2016 Result 1 infections, 78096 patient days Rating SIR: 0.34	1 infections, 78096 patient days	0.34
Q1 2015 - Q4 2015 Result 2 infections, 70031 patient days Rating SIR: 0.54	2 infections, 70031 patient days	0.54
Q1 2014 - Q4 2014 Result 2 infections, 73835 patient days Rating SIR: 0.53	2 infections, 73835 patient days	0.53
Q1 2013 - Q4 2013 Result 3 infections, 70370 patient days Rating SIR: 0.75	3 infections, 70370 patient days	0.75
Q1 2012 - Q4 2012 Result 1 infections, 69948 patient days Rating SIR: 0.25	1 infections, 69948 patient days	0.25
Q1 2012 - Q2 2012 Result 1 infections, 33566 patient days Rating SIR: 0.30	1 infections, 33566 patient days	0.30
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 36 infections, 77675 patient days Rating SIR: 1.21	36 infections, 77675 patient days	1.21
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 57 infections, 73790 patient days Rating SIR: 2.15	57 infections, 73790 patient days	2.15
Q1 2021 - Q4 2021 Result 43 infections, 72076 patient days Rating SIR: 1.35	43 infections, 72076 patient days	1.35
Q1 2020 - Q4 2020 Result 42 infections, 63920 patient days Rating SIR: 1.37	42 infections, 63920 patient days	1.37
Q1 2019 - Q4 2019 Result 48 infections, 71709 patient days Rating SIR: 1.46	48 infections, 71709 patient days	1.46
Q1 2018 - Q4 2018 Result 55 infections, 68930 patient days Rating SIR: 1.57	55 infections, 68930 patient days	1.57
Q1 2017 - Q4 2017 Result 56 infections, 66743 patient days Rating SIR: 1.71	56 infections, 66743 patient days	1.71
Q1 2016 - Q4 2016 Result 36 infections, 63005 patient days Rating SIR: 1.16	36 infections, 63005 patient days	1.16
Q1 2015 - Q4 2015 Result 24 infections, 57129 patient days Rating SIR: 0.48	24 infections, 57129 patient days	0.48
Q1 2014 - Q4 2014 Result 32 infections, 59788 patient days Rating SIR: 0.60	32 infections, 59788 patient days	0.60
Q1 2013 - Q4 2013 Result 29 infections, 57040 patient days Rating SIR: 0.55	29 infections, 57040 patient days	0.55
Q1 2012 - Q4 2012 Result 26 infections, 55675 patient days Rating SIR: 0.48	26 infections, 55675 patient days	0.48

Ped. CLABSI Measure	Result	SIR
Pediatric Medical ICU Q1 2015 - Q4 2015 Result 1 infections, 1411 central-line days Rating SIR: 0.24	1 infections, 1411 central-line days	0.24
Description Central Line-associated Bloodstream Infection data in the Medical Pediatric ICU summarized as a Standardized Infection Ratio.
Pediatric Medical-Surgical ICU Q1 2023 - Q4 2023 Result 5 infections, 4543 central-line days Rating SIR: 0.66	5 infections, 4543 central-line days	0.66
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 4 infections, 4297 central-line days Rating SIR: 0.56	4 infections, 4297 central-line days	0.56
Q1 2021 - Q4 2021 Result 5 infections, 4574 central-line days Rating SIR: 0.66	5 infections, 4574 central-line days	0.66
Q1 2020 - Q4 2020 Result 10 infections, 3823 central-line days Rating SIR: 1.58	10 infections, 3823 central-line days	1.58
Q1 2019 - Q4 2019 Result 7 infections, 4589 central-line days Rating SIR: 0.92	7 infections, 4589 central-line days	0.92
Q1 2018 - Q4 2018 Result 9 infections, 4574 central-line days Rating SIR: 1.19	9 infections, 4574 central-line days	1.19
Q1 2017 - Q4 2017 Result 10 infections, 4806 central-line days Rating SIR: 1.25	10 infections, 4806 central-line days	1.25
Q1 2016 - Q4 2016 Result 6 infections, 4021 central-line days Rating SIR: 0.90	6 infections, 4021 central-line days	0.90
Q1 2015 - Q4 2015 Result 3 infections, 4049 central-line days Rating SIR: 0.25	3 infections, 4049 central-line days	0.25
Q1 2014 - Q4 2014 Result 4 infections, 5014 central-line days Rating SIR: 0.27	4 infections, 5014 central-line days	0.27
Q1 2013 - Q4 2013 Result 6 infections, 4235 central-line days Rating SIR: 0.47	6 infections, 4235 central-line days	0.47
Q1 2012 - Q4 2012 Result 5 infections, 5663 central-line days Rating SIR: 0.49	5 infections, 5663 central-line days	0.49
Q1 2011 - Q4 2011 Result 8 infections, 6481 central-line days Rating SIR: 0.41	8 infections, 6481 central-line days	0.41
Q1 2010 - Q4 2010 Result 7 infections, 7616 central-line days Rating SIR: 0.31	7 infections, 7616 central-line days	0.31
Q1 2010 - Q2 2010 Result 1 infections, 4291 central-line days Rating SIR: 0.08	1 infections, 4291 central-line days	0.08
Pediatric Medical-Surgical ICU, Second Unit Q1 2018 - Q4 2018 Result 0 infections, 1591 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1591 central-line days ¹¹⁷	0.00 ¹¹⁷
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2017 - Q4 2017 Result 1 infections, 2067 central-line days Rating SIR: 0.29	1 infections, 2067 central-line days	0.29
Q1 2016 - Q4 2016 Result 0 infections, 1322 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1322 central-line days ¹¹⁷	0.00 ¹¹⁷
Pediatric Cardiothoracic ICU Q1 2023 - Q4 2023 Result 9 infections, 8888 central-line days Rating SIR: 0.61	9 infections, 8888 central-line days	0.61
Description Central Line-associated Bloodstream Infection data in the Pediatric Cardiothoracic ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 13 infections, 7938 central-line days Rating SIR: 0.99	13 infections, 7938 central-line days	0.99
Q1 2021 - Q4 2021 Result 12 infections, 8480 central-line days Rating SIR: 0.85	12 infections, 8480 central-line days	0.85
Q1 2020 - Q4 2020 Result 11 infections, 8363 central-line days Rating SIR: 0.79	11 infections, 8363 central-line days	0.79
Q1 2019 - Q4 2019 Result 11 infections, 8144 central-line days Rating SIR: 0.81	11 infections, 8144 central-line days	0.81
Q1 2018 - Q4 2018 Result 5 infections, 8090 central-line days Rating SIR: 0.37	5 infections, 8090 central-line days	0.37
Q1 2017 - Q4 2017 Result 13 infections, 7334 central-line days Rating SIR: 1.07	13 infections, 7334 central-line days	1.07
Q1 2016 - Q4 2016 Result 12 infections, 6249 central-line days Rating SIR: 1.16	12 infections, 6249 central-line days	1.16
Q1 2015 - Q4 2015 Result 6 infections, 5824 central-line days Rating SIR: 0.31	6 infections, 5824 central-line days	0.31
Q1 2014 - Q4 2014 Result 6 infections, 6207 central-line days Rating SIR: 0.29	6 infections, 6207 central-line days	0.29
Q1 2013 - Q4 2013 Result 3 infections, 4480 central-line days Rating SIR: 0.20	3 infections, 4480 central-line days	0.20